7.5. metastatic disease. recent analysis seer database reported patients m1 disease underwent primary site surgery exhibit survival benefit . systemic therapy metastatic disease selected based histology tumour. eau guidelines muscle-invasive metastatic bladder cancer followed uc predominant histology . even though urethral carcinoma patients included large clinical trials immunotherapy, far, terms response rates, subgroup analyses available . addition, urgent clinical need better address role local palliative treatment strategies primary urethral carcinoma including surgery, shown impact positively qol aspects selected patients advanced genital cancers . figure 7.1: management primary urethral carcinoma*ensure complete circumferential assessment penile-preserving/urethra-sparing surgery partial urethrectomy intended.**squamous cell carcinoma.***regional lymphadenectomy considered clinically enlarged lymph nodes.****consider neoadjuvant chemotherapy.*****in extensive bcg-unresponsive disease: consider (primary) cystoprostatectomy +/- urethrectomy + lymphadenectomy. bcg = bacillus calmette-gu√©rin; ct = computed tomography; mri = magnetic resonance imaging; puc = primary urethral carcinoma; tur = transurethral resection.